Autopsy report · NCT00451256

Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)

“Protocol-defined outcome in terms of efficacy would not be achieved.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 600 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Sarepta Therapeutics, Inc.

Sponsor type

Industry

Conditions

Cardiovascular Disease; Coronary Artery Bypass

Interventions

AVI-5126

Participants

600 (planned, not actual)

Sites

1

Countries

Ukraine

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.